124 related articles for article (PubMed ID: 27836528)
1. Aberrant bone marrow vascularization patterns in untreated patients with Gaucher disease type 1.
Klimkowska M; Machaczka M; Palmblad J
Blood Cells Mol Dis; 2018 Feb; 68():54-59. PubMed ID: 27836528
[TBL] [Abstract][Full Text] [Related]
2. Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows.
Zetterberg E; Vannucchi AM; Migliaccio AR; Vainchenker W; Tulliez M; Dickie R; Hasselbalch H; Rogers R; Palmblad J
Haematologica; 2007 May; 92(5):597-604. PubMed ID: 17488682
[TBL] [Abstract][Full Text] [Related]
3. Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis.
Carrai V; Miniati I; Guiducci S; Capaccioli G; Alterini R; Saccardi R; Conforti ML; Rigacci L; Rotunno G; Bosi A; Cerinic MM
Rheumatology (Oxford); 2012 Jun; 51(6):1042-8. PubMed ID: 22271757
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF), tissue inhibitors of metalloproteinase-1 (TIMP-1) and nail fold capillaroscopy changes in children and adolescents with Gaucher disease; relation to residual disease severity.
Salah NY
Cytokine; 2020 Sep; 133():155120. PubMed ID: 32535335
[TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow angiogenesis in aplastic anemia--a study of CD 34 and VEGF expression in bone marrow biopsies.
Gupta P; Khurana N; Singh T; Gupta D; Dhingra KK
Hematology; 2009 Feb; 14(1):16-21. PubMed ID: 19154660
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
Kim CK; Han DH; Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Lee KT; Won JH; Hong DS; Kim HK
Leuk Res; 2016 Nov; 50():21-28. PubMed ID: 27639703
[TBL] [Abstract][Full Text] [Related]
8. Increased angiogenesis in the bone marrow of patients with systemic mastocytosis.
Wimazal F; Jordan JH; Sperr WR; Chott A; Dabbass S; Lechner K; Horny HP; Valent P
Am J Pathol; 2002 May; 160(5):1639-45. PubMed ID: 12000716
[TBL] [Abstract][Full Text] [Related]
9. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
[TBL] [Abstract][Full Text] [Related]
10. Atypical cytomorphology of Gaucher cells is frequently seen in bone marrow smears from untreated patients with Gaucher disease type 1.
Markuszewska-Kuczynska A; Klimkowska M; Regenthal S; Bulanda A; Kämpe Björkvall C; Machaczka M
Folia Histochem Cytobiol; 2015; 53(1):62-9. PubMed ID: 25736845
[TBL] [Abstract][Full Text] [Related]
11. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
Zou WR; Liu T; Meng WT; Yu J; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
[TBL] [Abstract][Full Text] [Related]
12. Disproportion in Pericyte/Endothelial Cell Proliferation and Mechanisms of Intussusceptive Angiogenesis Participate in Bizarre Vessel Formation in Glioblastoma.
Díaz-Flores L; Gutiérrez R; González-Gómez M; García MD; Díaz-Flores L; González-Marrero I; Ávila J; Martín-Vasallo P
Cells; 2021 Oct; 10(10):. PubMed ID: 34685606
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow microvessel density and plasma angiogenic factors in myeloproliferative neoplasms: clinicopathological and molecular correlations.
Lekovic D; Gotic M; Skoda R; Beleslin-Cokic B; Milic N; Mitrovic-Ajtic O; Nienhold R; Sefer D; Suboticki T; Buac M; Markovic D; Diklic M; Cokic VP
Ann Hematol; 2017 Mar; 96(3):393-404. PubMed ID: 27924369
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
16. [Study on bone marrow microvascular density in hematological diseases].
Gao W; Song YQ; Li W; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):852-4. PubMed ID: 15631677
[TBL] [Abstract][Full Text] [Related]
17. Gaucheromas: When macrophages promote tumor formation and dissemination.
Ivanova M; Limgala RP; Changsila E; Kamath R; Ioanou C; Goker-Alpan O
Blood Cells Mol Dis; 2018 Feb; 68():100-105. PubMed ID: 27839983
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
[TBL] [Abstract][Full Text] [Related]
19. Increased angiogenesis-associated poor outcome in acute lymphoblastic leukemia: a single center study.
Todorovic M; Radisavljevic Z; Balint B; Andjelic B; Todorovic V; Jovanovic MP; Mihaljevic B
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):488-93. PubMed ID: 22417860
[TBL] [Abstract][Full Text] [Related]
20. GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM.
Medinger M; Tichelli A; Bucher C; Halter J; Dirnhofer S; Rovo A; Passweg J; Tzankov A
Bone Marrow Transplant; 2013 May; 48(5):715-21. PubMed ID: 23085826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
